Abrar, A., Hu, X., Akhtar, J., Jubayer, S., Noor Nabi Sayem, M., Sultana, S., Al Mamun, M. A., Bhuiyan, M. R., Malik, F., Amin, M. R., Alim, A., Gupta, R., Zhao, D., Farrell, M., Banigbe, B., Matsushita, K., Burka, D., Appel, L., Moran, A. E., & Choudhury, S. R. (2024). Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial. Heart, 110(17), 1090–1098. https://doi.org/10.1136/heartjnl-2024-324253

Papanastasiou, C. A., Bazmpani, M.-A., Kampaktsis, P. N., Zegkos, T., Gossios, T., Parcharidou, D., Kokkinidis, D. G., Tziatzios, I., Economou, F. I., Nikolaidou, C., Kamperidis, V., Tsapas, A., Ziakas, A., Efthimiadis, G., & Karamitsos, T. D. (2024). Cardiac magnetic resonance for ventricular arrhythmias: a systematic review and meta-analysis. Heart, heartjnl-2024-324182. https://doi.org/10.1136/heartjnl-2024-324182

Cheng, R., Kittleson, M. M., Wechalekar, A. D., Alvarez-Cardona, J., Mitchell, J. D., Scarlatelli Macedo, A. V., Dutra, J. P. P., Campbell, C. M., Liu, J. E., Landau, H. J., Davis, M. K., Morrissey, S., Casselli, S., Lousada, I., Seabra-Garcez, J. D., Szor, R. S., Ganatra, S., Trachtenberg, B., Maurer, M. S., … Lenihan, D. (2024). Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement. Heart, 110(12), 823–830. https://doi.org/10.1136/heartjnl-2023-323502

Ta, S., Li, J., Hsi, D. H., Hu, R., Lei, C., Shan, B., Li, W., Wang, J., Wang, B., Kang, N., Li, X., Liu, J., Qi, C., Huang, J., Han, Y., Ruan, F., Zhang, J., & Liu, L. (2024). Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up. Heart, 110(11), 792–799. https://doi.org/10.1136/heartjnl-2023-323606

Lumish, H. S., Liang, L. W., Hasegawa, K., Maurer, M. S., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2023). Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics. Heart, 109(24), 1837–1843. https://doi.org/10.1136/heartjnl-2023-322644

Gartshteyn, Y., Bhave, N., Joseph, M. S., Askanase, A., & Bernstein, E. J. (2022). Inflammatory and thrombotic valvulopathies in autoimmune disease. Heart, 109(8), 583–588. https://doi.org/10.1136/heartjnl-2021-319603

Li, J., Zhang, J., Shi, Y., Sievert, H., Taub, C. C., Bertog, S., Ta, S., Changhui, L., Senser, E., Wang, J., Hu, R., Huang, J., Ruan, F., Han, Y., Li, X., Wang, B., Zhao, X., Liu, J., Hsi, D. H., & Liu, L. (2022). Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation. Heart, 109(4), 289–296. https://doi.org/10.1136/heartjnl-2022-321597

Liang, L. W., Raita, Y., Hasegawa, K., Fifer, M. A., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2022). Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy. Heart, 108(22), 1807–1814. https://doi.org/10.1136/heartjnl-2021-320729

Stassen, J., Ewe, S. H., Butcher, S. C., Amanullah, M. R., Mertens, B. J., Hirasawa, K., Singh, G. K., Sin, K. Y., Ding, Z. P., Pio, S. M., Sia, C.-H., Chew, N., Kong, W., Poh, K. K., Cohen, D., Généreux, P., Leon, M. B., Ajmone Marsan, N., Delgado, V., & Bax, J. J. (2022). Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis. Heart, 108(17), 1401–1407. https://doi.org/10.1136/heartjnl-2022-320886

Morita, S., Malik, A. H., Kuno, T., Ando, T., Kaul, R., Yandrapalli, S., & Briasoulis, A. (2021). Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion. Heart, 108(8), 606–612. https://doi.org/10.1136/heartjnl-2021-319345